AINOHA

Ainoha develops a Class I digital medical device (CE marked, EU MDR 2017/745) dedicated to tracking and supporting perimenopause.

The app enables women aged 35 and over to track their wellbeing and symptoms, observe their menstrual cycle, monitor their hormone therapy, and share a clear health report with their healthcare professional.

Designed in France with a scientific committee of gynecologists and physicians, Ainoha already supports more than 10,000 women and is building a unique longitudinal database on perimenopause, with an average of 28.7 symptoms tracked per woman.

The company welcomes clinical, academic and industrial collaborations.